These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 35562149)

  • 1. Focal cortical dysplasia: Updates.
    Pinheiro J; Honavar M
    Indian J Pathol Microbiol; 2022 May; 65(Supplement):S189-S197. PubMed ID: 35562149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal cortical dysplasia pathology: diagnostic difficulty, classification, and utility for pathogenesis.
    Kapar O; Gurkan ZM; Dolgun M; Sencer A; Gürses C; Bilgic B
    Neurosurg Focus; 2022 Oct; 53(4):E6. PubMed ID: 36183176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SLC35A2 somatic variants in drug resistant epilepsy: FCD and MOGHE.
    Elziny S; Crino PB; Winawer M
    Neurobiol Dis; 2023 Oct; 187():106299. PubMed ID: 37739137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focal cortical dysplasias in temporal lobe epilepsy surgery: Challenge in defining unusual variants according to the last ILAE classification.
    Martinoni M; Marucci G; Rubboli G; Volpi L; Riguzzi P; Marliani F; Toni F; Naldi I; Bisulli F; Tinuper P; Michelucci R; Baruzzi A; Giulioni M
    Epilepsy Behav; 2015 Apr; 45():212-6. PubMed ID: 25812941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent SLC35A2 brain mosaicism in mild malformation of cortical development with oligodendroglial hyperplasia in epilepsy (MOGHE).
    Bonduelle T; Hartlieb T; Baldassari S; Sim NS; Kim SH; Kang HC; Kobow K; Coras R; Chipaux M; Dorfmüller G; Adle-Biassette H; Aronica E; Lee JH; Blumcke I; Baulac S
    Acta Neuropathol Commun; 2021 Jan; 9(1):3. PubMed ID: 33407896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cortical Dysplasia and the mTOR Pathway: How the Study of Human Brain Tissue Has Led to Insights into Epileptogenesis.
    Lee WS; Baldassari S; Stephenson SEM; Lockhart PJ; Baulac S; Leventer RJ
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissecting the genetic basis of focal cortical dysplasia: a large cohort study.
    Baldassari S; Ribierre T; Marsan E; Adle-Biassette H; Ferrand-Sorbets S; Bulteau C; Dorison N; Fohlen M; Polivka M; Weckhuysen S; Dorfmüller G; Chipaux M; Baulac S
    Acta Neuropathol; 2019 Dec; 138(6):885-900. PubMed ID: 31444548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.
    Nguyen LH; Mahadeo T; Bordey A
    J Neurosci; 2019 Apr; 39(14):2762-2773. PubMed ID: 30700531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropathological work-up of focal cortical dysplasias using the new ILAE consensus classification system - practical guideline article invited by the Euro-CNS Research Committee.
    Blümcke I; Mühlebner A
    Clin Neuropathol; 2011; 30(4):164-77. PubMed ID: 21726501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-hit DEPDC5 mutation is limited to dysmorphic neurons in cortical dysplasia type IIA.
    Lee WS; Stephenson SEM; Howell KB; Pope K; Gillies G; Wray A; Maixner W; Mandelstam SA; Berkovic SF; Scheffer IE; MacGregor D; Harvey AS; Lockhart PJ; Leventer RJ
    Ann Clin Transl Neurol; 2019 Jul; 6(7):1338-1344. PubMed ID: 31353856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiling PI3K-AKT-MTOR variants in focal brain malformations reveals new insights for diagnostic care.
    Pirozzi F; Berkseth M; Shear R; Gonzalez L; Timms AE; Sulc J; Pao E; Oyama N; Forzano F; Conti V; Guerrini R; Doherty ES; Saitta SC; Lockwood CM; Pritchard CC; Dobyns WB; Novotny E; Wright JNN; Saneto RP; Friedman S; Hauptman J; Ojemann J; Kapur RP; Mirzaa GM
    Brain; 2022 Apr; 145(3):925-938. PubMed ID: 35355055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal cortical dysplasia: a practical guide for neurologists.
    Balestrini S; Barba C; Thom M; Guerrini R
    Pract Neurol; 2023 Aug; 23(4):293-302. PubMed ID: 36823117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb.
    Nakashima M; Saitsu H; Takei N; Tohyama J; Kato M; Kitaura H; Shiina M; Shirozu H; Masuda H; Watanabe K; Ohba C; Tsurusaki Y; Miyake N; Zheng Y; Sato T; Takebayashi H; Ogata K; Kameyama S; Kakita A; Matsumoto N
    Ann Neurol; 2015 Sep; 78(3):375-86. PubMed ID: 26018084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic variants in diverse genes leads to a spectrum of focal cortical malformations.
    Lai D; Gade M; Yang E; Koh HY; Lu J; Walley NM; Buckley AF; Sands TT; Akman CI; Mikati MA; McKhann GM; Goldman JE; Canoll P; Alexander AL; Park KL; Von Allmen GK; Rodziyevska O; Bhattacharjee MB; Lidov HGW; Vogel H; Grant GA; Porter BE; Poduri AH; Crino PB; Heinzen EL
    Brain; 2022 Aug; 145(8):2704-2720. PubMed ID: 35441233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic double-hit in MTOR and RPS6 in hemimegalencephaly with intractable epilepsy.
    Pelorosso C; Watrin F; Conti V; Buhler E; Gelot A; Yang X; Mei D; McEvoy-Venneri J; Manent JB; Cetica V; Ball LL; Buccoliero AM; Vinck A; Barba C; Gleeson JG; Guerrini R; Represa A
    Hum Mol Genet; 2019 Nov; 28(22):3755-3765. PubMed ID: 31411685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good interobserver and intraobserver agreement in the evaluation of the new ILAE classification of focal cortical dysplasias.
    Coras R; de Boer OJ; Armstrong D; Becker A; Jacques TS; Miyata H; Thom M; Vinters HV; Spreafico R; Oz B; Marucci G; Pimentel J; Mühlebner A; Zamecnik J; Buccoliero AM; Rogerio F; Streichenberger N; Arai N; Bugiani M; Vogelgesang S; Macaulay R; Salon C; Hans V; Polivka M; Giangaspero F; Fauziah D; Kim JH; Liu L; Dandan W; Gao J; Lindeboom B; Blümcke I; Aronica E
    Epilepsia; 2012 Aug; 53(8):1341-8. PubMed ID: 22642611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinico-pathological characterisation of focal cortical dysplasia type IIb genetically defined by MTOR mosaicism.
    Wang Y; Yu T; Blümcke I; Cai Y; Sun K; Gao R; Wang Y; Fu Y; Wang W; Wang Y; Zhang G; Piao Y
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12874. PubMed ID: 36544434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ILAE consensus classification of focal cortical dysplasia: An update proposed by an ad hoc task force of the ILAE diagnostic methods commission.
    Najm I; Lal D; Alonso Vanegas M; Cendes F; Lopes-Cendes I; Palmini A; Paglioli E; Sarnat HB; Walsh CA; Wiebe S; Aronica E; Baulac S; Coras R; Kobow K; Cross JH; Garbelli R; Holthausen H; Rössler K; Thom M; El-Osta A; Lee JH; Miyata H; Guerrini R; Piao YS; Zhou D; Blümcke I
    Epilepsia; 2022 Aug; 63(8):1899-1919. PubMed ID: 35706131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism.
    Mirzaa GM; Campbell CD; Solovieff N; Goold C; Jansen LA; Menon S; Timms AE; Conti V; Biag JD; Adams C; Boyle EA; Collins S; Ishak G; Poliachik S; Girisha KM; Yeung KS; Chung BHY; Rahikkala E; Gunter SA; McDaniel SS; Macmurdo CF; Bernstein JA; Martin B; Leary R; Mahan S; Liu S; Weaver M; Doerschner M; Jhangiani S; Muzny DM; Boerwinkle E; Gibbs RA; Lupski JR; Shendure J; Saneto RP; Novotny EJ; Wilson CJ; Sellers WR; Morrissey M; Hevner RF; Ojemann JG; Guerrini R; Murphy LO; Winckler W; Dobyns WB
    JAMA Neurol; 2016 Jul; 73(7):836-845. PubMed ID: 27159400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. mTOR pathway: Insights into an established pathway for brain mosaicism in epilepsy.
    Gerasimenko A; Baldassari S; Baulac S
    Neurobiol Dis; 2023 Jun; 182():106144. PubMed ID: 37149062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.